NO970410L - Azaasparaginsyreanaloger som inhibitorer av interleukin-1 <beta> omdannende enzym - Google Patents
Azaasparaginsyreanaloger som inhibitorer av interleukin-1 <beta> omdannende enzymInfo
- Publication number
- NO970410L NO970410L NO970410A NO970410A NO970410L NO 970410 L NO970410 L NO 970410L NO 970410 A NO970410 A NO 970410A NO 970410 A NO970410 A NO 970410A NO 970410 L NO970410 L NO 970410L
- Authority
- NO
- Norway
- Prior art keywords
- interleukin
- inhibitors
- beta
- converting enzyme
- acid analogues
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
- C07C243/26—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C243/28—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
- C07C243/26—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C243/34—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a carbon skeleton further substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
- C07C243/38—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06052—Val-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/284,861 US5565430A (en) | 1994-08-02 | 1994-08-02 | Azaaspartic acid analogs as interleukin-1β converting enzyme inhibitors |
PCT/US1995/009668 WO1996003982A1 (en) | 1994-08-02 | 1995-07-31 | Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
NO970410D0 NO970410D0 (no) | 1997-01-30 |
NO970410L true NO970410L (no) | 1997-03-07 |
Family
ID=23091800
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO970410A NO970410L (no) | 1994-08-02 | 1997-01-30 | Azaasparaginsyreanaloger som inhibitorer av interleukin-1 <beta> omdannende enzym |
Country Status (8)
Country | Link |
---|---|
US (1) | US5565430A (de) |
EP (1) | EP0767661A4 (de) |
JP (1) | JPH10504816A (de) |
AU (1) | AU684993B2 (de) |
CA (1) | CA2196183A1 (de) |
FI (1) | FI970430A (de) |
NO (1) | NO970410L (de) |
WO (1) | WO1996003982A1 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6008217A (en) * | 1995-12-20 | 1999-12-28 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β converting enzyme |
US5874424A (en) * | 1995-12-20 | 1999-02-23 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β converting enzyme |
US6204261B1 (en) | 1995-12-20 | 2001-03-20 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β Converting enzyme inhibitors |
US5714484A (en) * | 1993-12-08 | 1998-02-03 | Prototek, Inc. | α-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
US5716929A (en) * | 1994-06-17 | 1998-02-10 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1β converting enzyme |
US5756466A (en) * | 1994-06-17 | 1998-05-26 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1β converting enzyme |
US6420522B1 (en) | 1995-06-05 | 2002-07-16 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β converting enzyme |
AU5122196A (en) * | 1995-03-31 | 1996-10-16 | Takeda Chemical Industries Ltd. | Cysteine protease inhibitor |
US5843904A (en) * | 1995-12-20 | 1998-12-01 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1βconverting enzyme |
US6416753B1 (en) | 1996-03-15 | 2002-07-09 | The General Hospital Corporation | Method for modulating apoptosis |
US6054487A (en) * | 1997-03-18 | 2000-04-25 | Basf Aktiengesellschaft | Methods and compositions for modulating responsiveness to corticosteroids |
US6184210B1 (en) | 1997-10-10 | 2001-02-06 | Cytovia, Inc. | Dipeptide apoptosis inhibitors and the use thereof |
KR100580333B1 (ko) * | 1997-10-10 | 2006-05-16 | 시토비아 인크. | 디펩티드 고사 억제제 및 그의 용도 |
ES2244178T3 (es) | 1998-03-09 | 2005-12-01 | Vertex Pharmaceuticals Incorporated | Derivados de 1,2-diazepan como inhibidores de la enzima convertidora de interleuquina-1 beta. |
EP1076563B1 (de) * | 1998-03-16 | 2005-05-11 | Cytovia, Inc. | Dipeptid kaspase inhibitoren und deren verwendung |
KR100898094B1 (ko) * | 1998-03-19 | 2009-05-18 | 버텍스 파마슈티칼스 인코포레이티드 | 카스파제의 억제제 |
DE19818732A1 (de) * | 1998-04-27 | 1999-10-28 | Bayer Ag | Arylphenylsubstituierte cyclische Ketoenole |
DE60030097T2 (de) | 1999-03-16 | 2007-03-08 | Cytovia, Inc., San Diego | Substituierte 2-aminobenzamin caspase inhibitoren und ihre verwendung |
MXPA01010127A (es) | 1999-04-09 | 2002-08-20 | Cytovia Inc | Inhibidores de la caspasa y el uso de los mismos. |
CN1235875C (zh) * | 1999-08-27 | 2006-01-11 | 西托维亚公司 | 取代的α-羟基酸天冬氨酸特异性半胱氨酸蛋白酶抑制剂及其用途 |
US6566338B1 (en) | 1999-10-12 | 2003-05-20 | Cytovia, Inc. | Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death |
PE20011350A1 (es) * | 2000-05-19 | 2002-01-15 | Vertex Pharma | PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE) |
AU2003211052A1 (en) * | 2002-02-11 | 2003-09-04 | Vertex Pharmaceuticals Incorporated | Phospholipids as caspase inhibitor prodrugs |
CA2484959A1 (en) | 2002-04-30 | 2003-11-13 | Yungjin Pharmaceutical Co., Ltd. | Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same |
TW200500343A (en) | 2002-12-20 | 2005-01-01 | Vertex Pharma | Caspase inhibitors and uses thereof |
PE20050159A1 (es) | 2003-05-27 | 2005-04-19 | Vertex Pharma | Derivados de acido 3-[2-(3-amino-2-oxo-2h-piridin-1-il)-acetilamino]-4-oxo-pentanoico como inhibidores de caspasa |
WO2005115362A1 (en) * | 2004-05-15 | 2005-12-08 | Vertex Pharmaceuticals Incorporated | Treating seizures using ice inhibitors |
GB0411056D0 (en) | 2004-05-18 | 2004-06-23 | Novartis Ag | Organic compounds |
CA2567080A1 (en) * | 2004-05-27 | 2005-12-15 | Vertex Pharmaceuticals Incorporated | Ice inhibitors for the treatment of autoinflammatory diseases |
US20140309172A1 (en) | 2010-11-05 | 2014-10-16 | Dagmar Ringe | Ice inhibiting compounds and uses thereof |
US9956260B1 (en) | 2011-07-22 | 2018-05-01 | The J. David Gladstone Institutes | Treatment of HIV-1 infection and AIDS |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69226820T2 (de) * | 1991-06-21 | 1999-05-12 | Merck & Co., Inc., Rahway, N.J. | Peptidylderivate als Inhibitoren von Interleukin-1B-konvertierenden Enzymen |
GB9123326D0 (en) * | 1991-11-04 | 1991-12-18 | Sandoz Ltd | Improvements in or relating to organic compounds |
CA2129976C (en) * | 1992-02-21 | 2002-09-17 | Kevin T. Chapman | Peptidyl derivatives as inhibitors of interleukin-1.beta. converting enzyme |
-
1994
- 1994-08-02 US US08/284,861 patent/US5565430A/en not_active Expired - Lifetime
-
1995
- 1995-07-31 JP JP8506684A patent/JPH10504816A/ja active Pending
- 1995-07-31 EP EP95928696A patent/EP0767661A4/de not_active Withdrawn
- 1995-07-31 WO PCT/US1995/009668 patent/WO1996003982A1/en not_active Application Discontinuation
- 1995-07-31 CA CA002196183A patent/CA2196183A1/en not_active Abandoned
- 1995-07-31 AU AU32354/95A patent/AU684993B2/en not_active Ceased
-
1997
- 1997-01-30 NO NO970410A patent/NO970410L/no not_active Application Discontinuation
- 1997-01-31 FI FI970430A patent/FI970430A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
EP0767661A4 (de) | 1998-06-10 |
WO1996003982A1 (en) | 1996-02-15 |
EP0767661A1 (de) | 1997-04-16 |
US5565430A (en) | 1996-10-15 |
JPH10504816A (ja) | 1998-05-12 |
AU3235495A (en) | 1996-03-04 |
FI970430A0 (fi) | 1997-01-31 |
NO970410D0 (no) | 1997-01-30 |
MX9700828A (es) | 1997-10-31 |
CA2196183A1 (en) | 1996-02-15 |
AU684993B2 (en) | 1998-01-08 |
FI970430A (fi) | 1997-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO970410L (no) | Azaasparaginsyreanaloger som inhibitorer av interleukin-1 <beta> omdannende enzym | |
FI942625A (fi) | Peptidisiä fosfinyylioksimetyyliketoneja interleukiini-1beta-muuttuvan entsyymin inhibiittoreina | |
MX9703564A (es) | Inhibidores de proteasa multicatalitica. | |
NO990855L (no) | Substituerte sykliske amin-metallprotease-inhibitorer | |
TR199801168T2 (xx) | �nterleukin-1 beta d�n��t�r�c� enzim inhibit�rleri. | |
MY106606A (en) | Cycloalkyl-substituted glutaramide antihypertensive agents. | |
NO931795D0 (no) | Dobbeltvirkende inhibitorer | |
BG102072A (en) | Rotamase enzymic activity inhibitors | |
DE3580057D1 (de) | Heterocylische mercaptocarbonsaeureamide, -imide und -nitrile als korrosionsinhibitoren. | |
BG104885A (en) | Novel heterocyclically substituted amides with cysteine protease-inhibiting effect | |
WO2000051993A3 (en) | Dihetero-substituted metalloprotease inhibitors | |
DK0419327T3 (da) | Aminosyrederivater, deres fremstilling og anvendelse som lægemidler | |
MX9605196A (es) | Halometilamidas como inhibidores de la proteasa il-1b. | |
NO964022L (no) | -2-antichymotrypsinanaloger med elastasehemmende aktivitet | |
CZ92298A3 (cs) | Inhibitory guanidin proteasy | |
FI103112B1 (fi) | Menetelmä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten 2-sakkarinyylimetyyliaryylikarboksylaattien valmistamiseksi | |
NO911459D0 (no) | Anvendelse av metallion-komplekser som belegginhibitorer. | |
DK371684A (da) | Octahydroindolizin-propansyrer og dermed beslaegtede forbindelser til anvendelse som enzym-inhibitorer | |
MX9704677A (es) | Procedimientos novedosos para preparar intermediarios de inhibidores de encefalinasa y enzima de conversion a angiotensina y sus intermediarios. | |
ATE28186T1 (de) | Alpha-allenyl-alpha-amino carbonsaeuren. | |
KR950700897A (ko) | 옥소-및 히드록시-치환된 탄화수소의 아민 유도체(Amine Derivatives of oxo- and hydroxy-substituted hydrocarbons) | |
EP0316907A3 (en) | Enzyme inhibitor and method of producing the same | |
EP0127090A3 (de) | Inhibitoren für Angiotensin umwandelnde Enzyme | |
DK580884A (da) | Nye substrater for d-aminosyreoxidase | |
ES2194436T3 (es) | Eliminador de radicales. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |